The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease.

Raj, Desh; Tomar, Bhawna; Lahiri, Amit; Mulay, Shrikant R

Raj, Desh; Tomar, Bhawna; Lahiri, Amit; Mulay, Shrikant R.

Afiliación

Raj D; Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, 110001, India.
Tomar B; Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
Lahiri A; Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, 110001, India.
Mulay SR; Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, 110001, India. Electronic address: shrikant.mulay@cdri.res.in.

Pharmacol Res ; 152: 104617, 2020 02.

Article en En | MEDLINE | ID: mdl-31881272

Asunto(s)

Hígado Graso/complicaciones; Microbioma Gastrointestinal; Intestinos; Riñón; Hígado; Insuficiencia Renal Crónica/etiología; Animales; Hígado Graso/microbiología; Humanos; Insuficiencia Renal Crónica/microbiología

Palabras clave

CKD; Fibrosis; Gut microbiota; Gut-kidney axis; Gut-liver axis; Inflammation; Insulin resistance; Intestinal barrier integrity; Liver-kidney axis; NAFLD; NASH

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica / Hígado Graso / Microbioma Gastrointestinal / Intestinos / Riñón / Hígado Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google